Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

CFO and Treasurer

President and CEO

COO and Chief of Staff

CSO and SVP, Research

Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company develops ONCR-021 for the treatment of non-small cell lung cancer, renal cell carcinoma, melanoma, and anaplastic thyroid cancer; and ONCR-788 for the treatment of small cell lung cancer, neuroendocrine prostate, and other neuroendocrine cancers. Oncorus, Inc. was incorporated in 2015 and is headquartered in Andover, Massachusetts.

Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients.

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2022-12-30	Premium	sold	Premium	Premium	Premium	-
2022-12-30	Premium	sold	Premium	Premium	Premium	-
2022-12-29	Premium	sold	Premium	Premium	Premium	-
2022-12-29	Premium	sold	Premium	Premium	Premium	-
2022-12-29	Premium	sold	Premium	Premium	Premium	-
2022-12-28	Premium	sold	Premium	Premium	Premium	-
2022-12-28	Premium	sold	Premium	Premium	Premium	-
2022-12-27	Premium	sold	Premium	Premium	Premium	-
2022-12-27	Premium	sold	Premium	Premium	Premium	-
2022-12-22	Premium	sold	Premium	Premium	Premium	-
2022-12-22	Premium	sold	Premium	Premium	Premium	-
2022-12-22	Premium	sold	Premium	Premium	Premium	-
2022-12-21	Premium	sold	Premium	Premium	Premium	-
2022-12-21	Premium	sold	Premium	Premium	Premium	-
2022-12-21	Premium	sold	Premium	Premium	Premium	-
2022-12-20	Premium	sold	Premium	Premium	Premium	-
2022-12-20	Premium	sold	Premium	Premium	Premium	-
2022-12-19	Premium	sold	Premium	Premium	Premium	-
2022-12-19	Premium	sold	Premium	Premium	Premium	-
2022-12-15	Premium	sold	Premium	Premium	Premium	-

ONCR - Oncorus Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for ONCR